Every 12 o'clock 丨 network public offering to buy Hengshuai shares for private placement? The company responded; Changchun high-tech recombinant human growth hormone was included in the Guangdong drug collection, and the stock price fell to a halt; the ChiNext index fell nearly 2%

Per Editor: Hu Ling

1丨 Online public offering to buy Hengshuai shares for private placement company: did not know

After every AI news, Hengshuai shares suffered a "black swan" event, and the opening fell rapidly on January 19, with a decline of more than 14% at one point. On the news side, on January 18, some media reported that a conversation on the Internet was suspected of questioning the Shanghai public offering group to buy the shares of Hengshuai shares of listed companies, which was a private placement. The relevant person of Hengshuai shares responded that he was not aware of the matters involved in the above rumors and did not participate in them. (China Securities News)

2丨Apnightly investment丨Chinext index fell nearly 2%, northbound funds bought a net of 3.6 billion yuan

Per AI express, the Shanghai Composite Index fell 9.97 points, or 0.28%, in early trading; the Shenzhen Component Index fell 167.17 points, or 1.16%, the ChiNext Index fell 61.5 points, or 1.96%, and the CSI 300 fell 27.76 points, or 0.58%. Northbound funds bought a net of 3.626 billion yuan. The top five industries with the highest increase were games 3.5%, cement building materials 3.24%, engineering consulting services 2.54%, Internet services 2.12%, and decoration building materials 1.95%. The top five industries that fell were energy metals -3.89%, batteries -3.13%, wind power equipment -2.46%, non-metallic materials -2.41%, and photovoltaic equipment -1.99%.

3丨 Changchun high-tech recombinant human growth hormone was included in the Guangdong drug collection

According to the "Guangdong Alliance Diclofenac and Other Drugs Centralized Procurement Documents" released on the website of the Guangdong Provincial Drug Trading Center on January 19, a variety of recombinant human growth hormones are in the collection catalog, including changchun high-tech holding subsidiary Changchun Kinsey Pharmaceutical's recombinant human growth hormone injection (Sinopharm S20050025).

Changchun high-tech plunged in the morning, as of the noon close, has sealed the stop, reported 227.60 yuan, the amount of 2.5 billion yuan.

4丨 Ministry of Transport: The mileage of the "14th Five-Year Plan" highway increased by about 300,000 kilometers

Every AI express, on January 19, at the press conference of the "14th Five-Year Plan" Modern Comprehensive Transportation System Development Plan, Xu Chengguang, chief planner of the Ministry of Transport and director of the Department of Comprehensive Planning, introduced that in terms of network layout, the development goals of increasing the highway mileage during the "14th Five-Year Plan" period by about 300,000 kilometers and the inland high-grade waterway by about 2,400 kilometers were proposed. (Securities Times E Corporation)

5丨 Guangzhou yesterday added 1 case of asymptomatic infected person associated with overseas imports, as an airline international flight cleaner

Every AI newsletter, the Guangzhou Municipal Health Commission notified that from 0:00 to 24:00 on January 18, 2022, there was a new case of asymptomatic infection in Guangzhou. Female, 36 years old, Chinese nationality, airline international flight cleaner, is a colleague of the asymptomatic infected person imported from overseas on January 14, once boarded the plane with the crew to clean, and was subjected to centralized isolation and observation as a close contact on the same day, and lived in a centralized place of residence for high-risk positions for the previous 14 days, implementing closed-loop management throughout the process. On January 18, he tested positive for the nucleic acid of the new coronavirus, that is, he was transferred to the Eighth Affiliated City Hospital of Guangzhou Medical University for isolation medical observation. After further examination and expert consultation, the diagnosis is an asymptomatic infection of the new crown virus. (CCTV News)

Disclaimer: The content and data in this article are for reference only, do not constitute investment advice, and are verified before use. Do so at your own risk.

Daily economic news